Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.

In English

Författare

  • Matthieu F Bastide
  • Wassilios G Meissner
  • Barbara Picconi
  • Stefania Fasano
  • Pierre-Olivier Fernagut
  • Michael Feyder
  • Veronica Francardo
  • Cristina Alcacer
  • Yunmin Ding
  • Riccardo Brambilla
  • Gilberto Fisone
  • A Jon Stoessl
  • Mathieu Bourdenx
  • Michel Engeln
  • Sylvia Navailles
  • Philippe De Deurwaerdère
  • Wai Kin D Ko
  • Nicola Simola
  • Micaela Morelli
  • Laurent Groc
  • Maria-Cruz Rodriguez
  • Eugenia V Gurevich
  • Maryka Quik
  • Michele Morari
  • Manuela Mellone
  • Fabrizio Gardoni
  • Elisabetta Tronci
  • Dominique Guehl
  • François Tison
  • Alan R Crossman
  • Un Jung Kang
  • Kathy Steece-Collier
  • Susan Fox
  • Manolo Carta
  • Angela Cenci Nilsson
  • Erwan Bézard
Visa allt

Summary, in English

Involuntary movements, or dyskinesia, represent a debilitating complication of levodopa (L-dopa) therapy for Parkinson's disease (PD). L-dopa-induced dyskinesia (LID) are ultimately experienced by the vast majority of patients. In addition, psychiatric conditions often manifested as compulsive behaviours, are emerging as a serious problem in the management of L-dopa therapy. The present review attempts to provide an overview of our current understanding of dyskinesia and other L-dopa-induced dysfunctions, a field that dramatically evolved in the past twenty years. In view of the extensive literature on LID, there appeared a critical need to re-frame the concepts, to highlight the most suitable models, to review the central nervous system (CNS) circuitry that may be involved, and to propose a pathophysiological framework was timely and necessary. An updated review to clarify our understanding of LID and other L-dopa-related side effects was therefore timely and necessary. This review should help in the development of novel therapeutic strategies aimed at preventing the generation of dyskinetic symptoms.

Publiceringsår

2015

Språk

Engelska

Sidor

96-168

Publikation/Tidskrift/Serie

Progress in Neurobiology

Volym

132

Issue

Jul 21

Dokumenttyp

Artikel i tidskrift

Förlag

Elsevier

Ämne

  • Neurology

Status

Published

Forskningsgrupp

  • Basal Ganglia Pathophysiology

ISBN/ISSN/Övrigt

  • ISSN: 1873-5118